Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials

The incidence and mortality rates from endometrial cancer are increasing. There have been no new drugs approved for the treatment of endometrial cancer in decades. The National Cancer Institute, Gynecologic Cancer Steering Committee identified the integration of molecular and/or histologic stratific...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: MacKay, Helen J., Levine, Douglas A., Bae-Jump, Victoria L., Bell, Daphne W., McAlpine, Jessica N., Santin, Alessandro, Fleming, Gini F., Mutch, David G., Nephew, Kenneth P., Wentzensen, Nicolas, Goodfellow, Paul J., Dorigo, Oliver, Nijman, Hans W., Broaddus, Russell, Kohn, Elise C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2017
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5663622/
https://ncbi.nlm.nih.gov/pubmed/29137450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19961
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia